Nishimura, R.A., Otto, C.M., Bonow, R.O., et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease. J Am Coll Cardiol 70 (2017), 252–289.
Mack, M.J., Leon, M.B., Smith, C.R., et al., PARTNER 1 trial investigators. 5-year outcomes of trans-catheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 385 (2015), 2477–2484.
Thyregod, H.G., Steinbrüchel, D.A., Ihlemann, N., et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers Nordic Aortic Valve Intervention (NOTION) randomized clinical trial. J Am Coll Cardiol 65 (2015), 2184–2194.
Rodriguez-Gabella, T., Voisine, P., Puri, R., Pibarot, P., Rodés-Cabau, J., Aortic bioprosthetic valve durability: incidence, mechanisms, predictors, and management of surgical and trans-catheter valve degeneration. J Am Coll Cardiol 70 (2017), 1013–1028.
Capodanno, D., Petronio, A.S., Prendergast, B., et al. Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 38 (2017), 3382–3390.
Lancellotti, P., Pibarot, P., Chambers, J., et al. Recommendations for the imaging assessment of prosthetic heart valves: a report from the European Association of Cardiovascular Imaging endorsed by the Chinese Society of Echocardiography, the Inter-American Society of Echocardiography, and the Brazilian Department of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 17 (2016), 589–590.
Foroutan, F., Guyatt, G.H., O'Brien, K., et al. Prognosis after surgical replacement with a bioprosthetic aortic valve in patients with severe symptomatic aortic stenosis: systematic review of observational studies. BMJ, 354, 2016, i5065.
Pibarot, P., Dumesnil, J.G., Prosthetic heart valves: selection of the optimal prosthesis and long-term management. Circulation 119 (2009), 1034–1048.
Bourguignon, T., Lhommet, P., El Khoury, R., et al. Very long-term outcomes of the Carpentier-Edwards Perimount aortic valve in patients aged 50–65 years. Eur J Cardiothorac Surg 49 (2016), 1462–1468.
Toggweiler, S., Humphries, K.H., Lee, M., et al. 5-year outcome after transcatheter aortic valve implantation. J Am Coll Cardiol 61 (2013), 413–419.
Dvir D. First look at long-term durability of transcatheter heart valves. Assessment of valve function up to 10-years after implantation. Paper presented at: EuroPCR; May 17–20, 2016; Paris, France.
Eltchaninoff, H., Durand, E., Avinée, G., et al. Assessment of structural valve deterioration of transcatheter aortic bioprosthetic balloon-expandable valves using the new European consensus definition. EuroIntervention 14 (2018), e264–e271.
Holy, E.W., Kebernik, J., Abdelghani, M., et al. Long-term durability and haemodynamic performance of a self-expanding transcatheter heart valve beyond five years after implantation: a prospective observational study applying the standardised definitions of structural deterioration and valve failure. EuroIntervention 14 (2018), e390–e396.
Kovac, J., Schuler, G., Gerckens, U., et al. Four-year experience with the Core Valve transcatheter heart valve. EuroIntervention 12 (2016), e1039–e1046.
Sawaya, F., Kappetein, A.P., Wisser, W., et al. Five-year haemodynamic outcomes of the first-generation SAPIEN balloon-expandable transcatheter heart valve. EuroIntervention 12 (2016), 775–782.
Blackman, D.J., Saraf, S., MacCarthy, P.A., et al. Long-term durability of transcatheter aortic valve prostheses. J Am Coll Cardiol 73 (2019), 537–545.
Søndergaard, L., Ihlemann, N., Capodanno, D., et al. Durability of transcatheter and surgical bioprosthetic aortic valves in patients at lower surgical risk. J Am Coll Cardiol 73 (2019), 546–553.
Flameng, W., Herregods, M.C., Vercalsteren, M., Herijgers, P., Bogaerts, K., Meuris, B., Prosthesis-patient mismatch predicts structural valve degeneration in bioprosthetic heart valves. Circulation 121 (2010), 2123–2129.
Salaun, E., Haïfa Mahjoub, H., Girerd, N., et al. Rate, timing, correlates, and outcomes of hemodynamic valve deterioration after bioprosthetic surgical aortic valve replacement. Circulation 138 (2018), 971–985.
